Clinical and treatment characteristics of children with attention- deficit/hyperactivity disorder in psychiatric practice

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 37, Issue 12, 1998, Pages 1262-1270

  Zarin, Deborah A ^a   Suarez, Ana P ^c   Pincus, Harold Alan ^a   Kupersanin, Eve ^c   Zito, Julie Magno ^b  

^a AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NONE

Author keywords

Attention deficit hyperactivity disorder; Methylphenidate; Observational study; Practice based research; Psychiatry

Indexed keywords

AMPHETAMINE; CLONIDINE; DEXAMPHETAMINE; GUANFACINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PEMOLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COMORBIDITY; DRUG EFFECT; FEMALE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTPATIENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRIVATE PRACTICE; PSYCHIATRY; TREATMENT PLANNING;

EID: 0031740446     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199812000-00009     Document Type: Article

References (31)

1. American Academy of Child and Adolescent Psychiatry (1997), Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:855-121S
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Barkley RA (1990), Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford
4. Biederman J, Newcorn J, Sprich S (1991), Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577
5. Cantwell DP (1996), Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35:978-987
6. Epstein MA, Shaywitz SE, Shaywitz BA, Woolston JL (1991), The boundaries of attention deficit disorder. J Learn Disabil 24:78-86
7. Goldman LS, Genel M, Bezman RJ, Slanetz PF (1998), Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 279:1100-1107
8. Greenhill LL, Abikoff HB, Arnold LE et al. (1996), Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 34:1-10
9. Hazell PL, McDowell MJ, Walton JM (1996), Management of children prescribed psychostimulant medication for attention deficit hyperactivity disorder in the Hunter region of NSW. Med J Aust 165:477-480
10. Hinshaw SP, March JS, Abikoff H et al. (1997), Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. J Attention Disord 1:217-234
11. Jacobvitz D, Sroufe LA, Steward M, Leffert N (1990), Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry 29:677-688
12. Jensen PS, Martin D, Cantwell DP (1997), Comorbidity of ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry 36:1065-1079
13. Moser SE, Kallail KJ (1995), Attention-deficit hyperactivity disorder: management by family physicians. Arch Fam Med 4:241-244
14. Rappley MD, Gardiner JP, Jetton RCH (1995), The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 149:675-679
15. Richters JE, Arnold LE, Jenson PS et al. (1995), NIMH Collaborative Multisite Multimodal Treatment Study of Children With ADHD, I: background and rationale. J Am Acad Child Adolesc Psychiatry 34:987-1000
16. Safer DJ, Krager JM (1988), A survey of medication treatment for hyperactive/ inattentive students. JAMA 260:2256-2258
17. Safer DJ, Zito JM, Fine EM (1996), Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98:1084-1088
18. Shaffer D, Gould MS, Brasie J et al. (1983), A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231
19. Silver LB (1992), Attention-Deficit Hyperactivity Disorder: A Clinical Guide to Diagnosis and Treatment. Washington, DC: American Psychiatric Press
20. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S (1996), Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-423
21. Swanson JM (1993), Effect of stimulant medication on children with attention deficit disorder: a "review of reviews." Except Child 60:154-162
22. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP (1998), Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429-433
23. Vitiello B, Hoagwood K (1997), Pediatric pharmacoepidemiology: clinical applications and research priorities in children's mental health. J Child Adolesc Psychopharmacol 7:287-290
24. Waslick B, Greenhill LL (1997), Attention-deficit hyperactivity disorder. In: Textbook of Child and Adolescent Psychiatry, Wiener JM, ed. Washington, DC: American Psychiatric Press, pp 389-410
25. Wasserman R, Bocian A, Baker A et al. (1997), Attentional and hyperactivity problems seen in primary care (abstract). Ambul Child Health 3:184
26. West JC, Zarin DA, Pincus HA (1997), Clinical and psychopharmacologic practice patterns of psychiatrists in routine practice. Psychopharmacol Bull 33:79-85
27. Wolraich ML, Lindgren S, Stromquist A, Milich R, Davis C, Watson D (1990), Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 86:95-101
28. Zarin DA, Pincus HA, Peterson BD et al. (1998a), Characterizing psychiatry with findings from the 1996 National Survey of Psychiatric Practice. Am J Psychiatry 155:397-404
29. Zarin DA, Pincus HA, West JC, McIntyre JS (1997), Practice-based research in psychiatry. Am J Psychiatry 154:1199-1208
30. Zarin DA, Tanielian TL, Suarez AP, Marcus SC (1998b), Treatment of attention-deficit hyperactivity disorder. Psychiatr Serv 49:171
31. Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA (1997), Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull 33:143-147